TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation April 28, 2006
TCL Archive FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting March 19, 1976
TCL Archive Also Unclear whether HHS Secretary Tommy Thompson will depart as previously planned. November 5, 2004
TCL Archive In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC September 4, 1998
